| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.04 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.05 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |